Skip to content

HealthEquity HQY Free cash flow margin

Free cash flow margin at other companies

UnitedHealth Group logo
UnitedHealth GroupUNH
4.4%-1.7pp
Webster Financial Corporation logo
Webster Financial CorporationWBS
41%-5.3pp
Willis Towers Watson logo
Willis Towers WatsonWTW
15.8%+3.4pp
CVS Health logo
CVS HealthCVS
1.8%
Centene logo
CenteneCNC
3.6%+2.7pp
Oscar Health logo
Oscar HealthOSCR
-8.2%

Other financials

Income statement

See full
Revenue$354.6M+7.2%
Gross profit$256.3M+14.3%
Operating income$103.0M+23.9%
Net income$69.4M+28.8%
EPS (diluted)$0.82+34.4%

Balance sheet

See full
Cash & equivalents$265.4M-7.8%
Total debt$984.7M-11.0%
Total equity$2.0B-3.6%
Total assets$3.3B-3.2%

Cash flow

See full
Operating cash flow$97.5M+50.6%
CapEx$362.0K+321%
Free cash flow$97.2M+50.3%

Valuation

See full
Market cap$7.12B-6.7%
Enterprise value$7.84B-7.2%
P/E30.9×-31.8×
P/S5.3×-0.8×

Profitability

See full
Gross margin70.7%+5.2pp
Operating margin25.6%+9.2pp
Net margin17.3%+7.5pp

Returns & leverage

See full
Return on equity11.1%+5.3pp
Debt / equity0.5×0.0×
Current ratio3.4×-0.6×

Where this comes from

Calculated from HealthEquity’s reported figures.

Based on trailing twelve months.

The official record: HealthEquity’s 10-Q, filed May 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about HealthEquity's free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is HealthEquity's free cash flow margin?
HealthEquity (HQY) reported free cash flow margin of 36.5% in Q1 2026.
How has HealthEquity's free cash flow margin changed year-over-year?
HealthEquity's free cash flow margin increased by 34.2% year-over-year, from 27.2% to 36.5%.
What is the long-term trend for HealthEquity's free cash flow margin?
Over 5 years (2021 to 2026), HealthEquity's free cash flow margin has grown at a 8.6% compound annual growth rate (CAGR), from 23% to 34.7%.
What does free cash flow margin mean?
Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.